أيرلندا - الإنجليزية - HPRA (Health Products Regulatory Authority)

sanofi pasteur - haemophilus influenzae type b, conjugate with tetanus protein - pdr+solv for soln for inj - 10mcg/0.5m microgram/ml - hemophilus influenzae b vaccines

أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

fort dodge australia pty limited - haemophilus paragallinarum type a | haemophilus paragallinarum type c - immunotherapy - poultry | breeders | broiler | chickens | chicks | chooks | day old chicks | hatchlings | layers - coryza | vaccine | equine rotavirus | infectious coryza

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - haemophilus influenzae vaccine, tetanus toxoid conjugate 10ug (20-40mcg of tetanus toxoid per dose) - powder for injection with diluent - 0.5 ml - excipient: sodium chloride water for injection active: haemophilus influenzae vaccine, tetanus toxoid conjugate 10ug (20-40mcg of tetanus toxoid per dose) excipient: lactose water for injection - hiberix is indicated for active immunisation of all infants from the age of 6 weeks against disease caused by hib. hiberix does not protect against diseases due to other types of h. influenzae, nor against meningitis caused by other organisms.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - diphtheria toxoid, adsorbed 30 [iu] (not less than); hepatitis b surface antigen, recombinant 10ug; pertactin 8ug; pertussis filamentous haemagglutinin 25ug; pertussis toxoid, adsorbed 25ug; polio virus type 1 40 dagu (/dose); polio virus type 2 8 dagu (/dose); polio virus type 3 32 dagu (/dose); tetanus toxoid, adsorbed 40 [iu] (not less than); haemophilus influenzae vaccine, tetanus toxoid conjugate 10ug (covalently bonded to tetanus toxoid 20 - 40micrograms) - suspension for injection - 0.5 ml - active: diphtheria toxoid, adsorbed 30 [iu] (not less than) hepatitis b surface antigen, recombinant 10ug pertactin 8ug pertussis filamentous haemagglutinin 25ug pertussis toxoid, adsorbed 25ug polio virus type 1 40 dagu (/dose) polio virus type 2 8 dagu (/dose) polio virus type 3 32 dagu (/dose) tetanus toxoid, adsorbed 40 [iu] (not less than) excipient: aluminium medium 199 sodium chloride water for injection active: haemophilus influenzae vaccine, tetanus toxoid conjugate 10ug (covalently bonded to tetanus toxoid 20 - 40micrograms) excipient: aluminium as aluminium phosphate lactose - infanrix hexa is indicated for primary and booster vaccination of infants against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis and haemophilus influenzae type b.

نيوزيلاندا - الإنجليزية - Medsafe (Medicines Safety Authority)

wyeth (nz) ltd - diphtheria toxoid, adsorbed 25 lf u/ml; haemophilus influenzae type b oligosaccharide vaccine-crm 197 conjugate 50 µg/ml; haemophilus influenzae type b vaccine 20 µg/ml; pertussis vaccine, adsorbed 32 iou; tetanus toxoid, adsorbed 10 lf u/ml - suspension for injection - 0.5 ml - active: diphtheria toxoid, adsorbed 25 lf u/ml haemophilus influenzae type b oligosaccharide vaccine-crm 197 conjugate 50 µg/ml haemophilus influenzae type b vaccine 20 µg/ml pertussis vaccine, adsorbed 32 iou tetanus toxoid, adsorbed 10 lf u/ml excipient: aluminium sodium chloride thiomersal water for injection

إسرائيل - الإنجليزية - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; fillamentous haemagglutinin (fha); haemophilus influenzae type b polysaccharide; inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin; pertussis toxoid (pt); tetanus toxoid - powder and suspension for suspension for injection - diphtheria toxoid nlt 60 iu/ml; inactivated polio virus (ipv) type 3 64 du / 1 ml; inactivated polio virus (ipv) type 2 16 du / 1 ml; inactivated polio virus (ipv) type 1 80 du / 1 ml; pertussis toxoid (pt) 50 mcg/ml; fillamentous haemagglutinin (fha) 50 mcg/ml; pertactin 16 mcg/ml; tetanus toxoid nlt 80 iu/ml; haemophilus influenzae type b polysaccharide 20 mcg/vial - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - diphtheria-hemophilus influenzae b-pertussis-poliomyelitis-tetanus - active immunisation in infants from the age of 2 months to 5 years against diptheria, tetanus, pertussis, poliomyelitis and haemophilus influenza type b. booster dose for children who have previously been immunised with dtp, polio and hib antigens

سنغافورة - الإنجليزية - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - (mena lyo) meningococcal group a oligosaccharide conjugated to crm197 protein; (mencwy) meningococcal group c oligosaccharide conjugated to crm197 protein; (mencwy) meningococcal group w-135 oligosaccharide conjugated to crm197 protein; (mencwy) meningococcal group y oligosaccharide conjugated to crm197 protein - injection, powder, for solution - 10 microgram conjugated to 16.7-33.3 microgram - (mena lyo) meningococcal group a oligosaccharide conjugated to crm197 protein 10 microgram conjugated to 16.7-33.3 microgram; (mencwy) meningococcal group c oligosaccharide conjugated to crm197 protein 5 microgram conjudated to 7.1-12.5 microgram; (mencwy) meningococcal group w-135 oligosaccharide conjugated to crm197 protein 5 microgram conjugated to 3.3-8.3 microgram; (mencwy) meningococcal group y oligosaccharide conjugated to crm197 protein 5 microgram conjugated to 5.6-10 microgram

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc; distributor: zuellig pharma corporation - diphtheria, tetanus, pertussis (acellular poliomyelitis (inactivated) vaccine and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension and powder for suspension for injection (im) - after reconstitution, each dose (0.5 ml) contains: diphtheria toxoid tetanus toxoid bordetella pertussis antigen pertussis toxoid filamentous hemagglutinin poliovirus (inactivated) >30 iu >40 iu polysaccharide influenzae type b conjugated to tetanus protein of haemophilus 10 mcg 18-30 mcg 25 mcg 25 mcg type i poliomyelitis virus (inactivated) 40 d antigen units type ii poliomyelitis virus (inactivated) 8 d antigen units type iii poliomyelitis virus (inactivated) 32 d' antigen

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

n/a; importer: sanofi pasteur, inc.; distributor: zuellig pharma corporation - diphtheria, tetanus, pertussis (acellular component), hepatitis b, poliomyelitis (inactivated) and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension for injection (im) - formulation: each dose (0.5 ml) contains: diphtheria toxoid' tetanus toxoid ' bordetella pertussis antigen pertussis toxoid' filamentous hemagglutinin' poliovirus (inactivated)2.3 type i (mahoney) strain nlt 20 iu nlt 40 iu hepatitis b surface antigen haemophilus influenzae type b polysaccharide phosphate) 10 mcg (polyribosylribitol 12 mcg conjugate to tetanus protein 22-36 mcg 25 mcg 25 mcg 40 d antigen units type ii (mef-1) strain" type iii (saukett) strain1 8 d antigen units 32 d antigen units 'adsorbed on aluminium hydroxide, hydrated (al(oh)3) 2produced in yeast cells (saccharomyces cerevisiae) by recombinant dna technology 3adsorbed on aluminium phosphate (aipo4) *propagated in vero cells

الفلبين - الإنجليزية - FDA (Food And Drug Administration)

medical vaccines online deliveries - diptheria,tetanus, pertussis, hepatitis b and haemophilus influenzae type b conjugate vaccine (adsorbed) - suspension for injection im - 0.5ml